Drug Facts
Active ingredient Purpose
Levonorgestrel 1.5 mg.....................Emergency contraceptive
Use
for women to reduce chance of pregnancy after
unprotected sex (if a contraceptive failed or if you did not use
birth control)
Warnings
Allergy alert: Do not use if you have ever had an allergic
reaction to levonorgestrel
Sexually transmitted diseases (STDs) alert: This product
does not protect against HIV/A DS or other STDs
Do not use
if you are already pregnant (because it will not work)
for regular birth control
Ask a doctor or pharmacist before use if you are taking
efavirenz (HIV medication) or rifampin (tuberculosis
treatment) or medication for seizures (epilepsy). These
medications may reduce the effectiveness of levonorgestrel.
When using this product you may have
menstrual changes
tiredness
breast pain
nausea
headache
vomiting
lower stomach (abdominal) pain
dizziness
Keep out of reach of children. In case of overdose, get
medical help or contact a Poison Control center right away.
Directions
take as soon as possible within 72 hours (3 days) after
unprotected sex. The sooner you take it the better it
will work.
if you vomit within 2 hours after taking the medication,
call a healthcare professional to find out if you should
repeat the dose
Other information
read the instructions,
warnings and enclosed product leaflet before use
Drug Facts (continued)
this product works mainly by preventing ovulation
(egg release). It may also prevent fertilization of a
released egg (joining of sperm and egg) or attachment
of a fertilized egg to the uterus (implantation).
do not use if carton is open or blister seal is
broken or missing
store at 20-25°C (68-77°F)
Drug Facts (continued)
Inactive ingredients
colloidal silicon
dioxide, corn starch, lactose monohydrate,
magnesium stearate, potato starch, talc
Questions?
Call 1-800-330-1271 or
visit www.PlanBOneStep.com
1 Tablet Levonorgestrel 1.5 mg
levonorgestrel 1.5 mg
NDC 69536-162-99
emergency on racept ve
On Ta e
t
Reduces chance of
pregnancy after
unprotected sex.
Not for regular birth control.
Visit us at:
www.PlanBOneStep.com
The sooner you
take it, the more
effective it will be
Take as soon as
possible within 72
hours (3 days) after
unprotected sex
Will not harm an
existing pregnancy
O T
O p
emergency
contraceptive
Tab p
Distributed by:
Foundation Consumer
Healthcare, LLC (FCH)
Pittsburgh PA 15205
©2018
Made in Hungary
0 00000 00000 0
80% UPC A
F.P.O.
DRUG FACTS FONT SPECS
DRUG FACTS TITLE ............... 10pt. Hel. Bold Oblique
DRUG FACTS (CONTINUED) ......................... 8pt. Hel.
HEADINGS ................................ 8pt. Hel. Bold Oblique
SUB-HEADINGS ..................................... 6pt. Hel. Bold
BODY TEXT .................................................... 6pt. Hel.
TEXT – HORIZONTAL SCALING......<39 char. per inch
LEADING ............................................................. .05pt.
BULLETS ................................... 5pt. Square or Round
THICK RULES & BOUNDING BOX .................... 2.5pt.
THIN RULES ......................................................... .5pt.
A ON O S M E T C RE O N A ON O UM R E T C RE O N A ON O UM R E T C RE O N A O C N U ER A T C E O N T O C N U E H A H A E U D T N C N U E H A H A E
F U D T N
C
N
D
T
I
N
O UM R E L C RE O N A ON O S M R E T C RE O N A ON O UM R E T C RE O N A ON N U ER A T C E O N TO C N U ER A T C E U D T N C N U E H A H A E F D T N C NS
FCH C
FCH FCH FC
H FCH FCH
FCH FCH FC
CH FCH FCH
CH FC FCH
Reference ID: 4371429
This label may not be the latest approved by FDA.
For current labeling information, please visit https://www.fda.gov/drugsatfda
PUSH THROUGH FOIL
Dist. by:
Foundation Consumer
Healthcare, LLC
Pittsburgh, PA 15205
LOT: 000000 EXP:00/00
1.5 mg levonorgestrel tablet
FONT SPECS
SOI .............. 6.05pt Ocean Sans MM – 512 SB 475 NO
DISTRIBUTED BY................... 7pt Ocean Sans Regular
Reference ID: 4371429
This label may not be the latest approved by FDA.
For current labeling information, please visit https://www.fda.gov/drugsatfda